Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05356793
PHASE2

The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis

Sponsor: Sacsh

View on ClinicalTrials.gov

Summary

The objective of this study is to evaluate the efficacy of Sasch1, a novel anti-infective eyedrop, in the treatment of acute infectious conjunctivitis.

Official title: A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2021-03-01

Completion Date

2022-03-28

Last Updated

2026-04-14

Healthy Volunteers

No

Interventions

DRUG

SCH-1

Novel anti-infective eyedrop

DRUG

Placebo

SCH-1 vehicle minus active components eyedrop

Locations (1)

Jacqueline Dauhajre, MD

Jackson Heights, New York, United States